CID 135536943

Gisadenafil

Structural Information

Molecular Formula
C23H33N7O5S
SMILES
CCC1=C2C(=NN1CCOC)C(=O)NC(=N2)C3=C(N=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC
InChI
InChI=1S/C23H33N7O5S/c1-5-18-19-20(27-30(18)12-13-34-4)22(31)26-21(25-19)17-14-16(15-24-23(17)35-7-3)36(32,33)29-10-8-28(6-2)9-11-29/h14-15H,5-13H2,1-4H3,(H,25,26,31)
InChIKey
YPFZMBHKIVDSNR-UHFFFAOYSA-N
Compound name
5-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylpyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-6H-pyrazolo[4,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

8
References

1887
Patents

519.2264 Da
Monoisotopic Mass

0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 520.23368 225.3
[M+Na]+ 542.21562 237.4
[M+NH4]+ 537.26022 226.6
[M+K]+ 558.18956 232.8
[M-H]- 518.21912 224.9
[M+Na-2H]- 540.20107 228.0
[M]+ 519.22585 227.0
[M]- 519.22695 227.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe